Business
Strategic collaboration with DeepVerge plc
Strategic collaboration with DeepVerge plc.
About this update from Abingdon Health Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 3116G\n Abingdon Health PLC\n 29 March 2022\n \n \n \n Abingdon Health plc\n (\"Abingdon\" or \"the Company\")\n \n Strategic collaboration with DeepVerge plc\n \n Focused on the\n development, manufacturing and commercialisation of lateral flow tests to support DeepVerge's Modern Water and Life Science divisions\n \n \n \n York, U.K. 29 March 2022: Abingdon Health plc (AIM: ABDX), a leading international developer and manufacturer of high quality and effective rapid tests, announces that it has signed a Memorandum of Understanding (\"MoU\") with DeepVerge plc (AIM: DVRG) (\"DeepVerge\"), an environmental and life science group that develops and applies AI and IoT technology for the analysis and identification of bacteria, virus and toxins, leading to a commercial agreement for development and manufacture of a range of lateral flow tests (\"LFTs\") for DeepVerge's Modern Water and Life Science divisions. \n \n \n \n \n The MoU has been signed to enable the potential integration of the respective technologies of both DeepVerge and Abingdon. DeepVerge and Abingdon intend to enter into a longer-term commercial agreement, with Abingdon manufacturing and DeepVerge commercialising the new products through its production, sales, marketing and distribution channel partners around the world.\n \n \n \n \n \n Modern Water\n \n \n Modern Water is the environmental division of DeepVerge that has developed and commercialised cutting-edge technology focused on monitoring of contaminated water and decontamination of wastewater. Abingdon and DeepVerge will work on the development of LFT devices to detect dangerous pathogens and chemicals in household drinking and wastewater. This will add an extra layer of detection to the current Modern Water range of equipment and services by incorporating an LFT into a hand-held mobile unit. The results of these LFT devices can be digitally scanned using a mobile app, with the potential to incorporate Abingdon's proprietary AppDx® technology. \n \n Future potential developments for water testing that are complementary to the current Modern Water portfolio include the pepper mottle mosaic virus as a potential marker for human faecal matter in water and the automated multiplexing project bringing in influenza A, influenza B, Cryptosporidium etc...